Get started
AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)

AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

AMGND chart


Full chart

Key facts today

HSBC raised its price target for Amgen Inc. to $385 from $369. Analysts' targets for Amgen range from $200 to $405, indicating diverse expectations for the stock's performance.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪173.16 B‬ USD
Dividend yield (indicated)
2.61%
Price to earnings Ratio (TTM)
43.915
Basic EPS (TTM)
0.260 USD
Net income (FY)
‪2.45 B‬ USD
Revenue (FY)
‪10.20 B‬ USD
Shares float
—
Beta (1Y)
0.42

About Amgen Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Robert A. Bradway
Website
amgen.com
Headquarters
Thousand Oaks
Founded
1980
ISIN
ARDEUT110665
FIGI
BBG000HDW649
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AMGND news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AMGND highest yielding bonds


AMGN.GA
Amgen Inc. 8.125% 01-APR-2097
Yield to maturity
6.16%
Maturity date
Apr 1, 2097
US31162BP4
AMGEN 12/43
Yield to maturity
5.94%
Maturity date
May 15, 2043
US31162DU1
AMGEN 23/63
Yield to maturity
5.78%
Maturity date
Mar 2, 2063
AMGN.GV
Amgen Inc. 6.4% 01-FEB-2039
Yield to maturity
5.73%
Maturity date
Feb 1, 2039
US31162BH2
AMGEN 2042
Yield to maturity
5.67%
Maturity date
Jun 15, 2042
US31162DT4
AMGEN 23/53
Yield to maturity
5.66%
Maturity date
Mar 2, 2053
US31162DS6
AMGEN 23/43
Yield to maturity
5.62%
Maturity date
Mar 2, 2043
AMGN.GU
Amgen Inc. 6.9% 01-JUN-2038
Yield to maturity
5.61%
Maturity date
Jun 1, 2038
US31162BZ2
AMGEN 15/45
Yield to maturity
5.57%
Maturity date
May 1, 2045
US31162DK3
AMGEN 22/53
Yield to maturity
5.57%
Maturity date
Mar 1, 2053
AMGN.HG
Amgen Inc. 5.15% 15-NOV-2041
Yield to maturity
5.56%
Maturity date
Nov 15, 2041

Explore more bonds 

Sparks


Curated watchlists where AMGND is featured.

See all sparks